On average, a pharmacy works with around 100 laboratory suppliers, each with its systems and procedures for promotion, restocking, and customer support. Without a centralised solution, pharmacists spend over 30% of their time managing these interactions, juggling emails, handwritten notes, and Excel files. This scattered approach creates a heavy mental load, leads to missed business opportunities, and impacts pharmacy profitability. In fact, errors generated by inefficient processes impact about 0.5% of profitability.
To solve these challenges, Faks has developed a unique platform — a commercial back office that centralises, organises, and automates exchanges between pharmacies and suppliers. Today, the startup raised €6M in a funding round led by Speedinvest, supported by existing investors Connect Ventures, Seedcamp, and FJ Labs. The company has not publicly disclosed its valuation to TFN.
With this new investment, Faks plans to boost automation with AI and new features. To support this evolution, the startup will double its R&D team, growing from 7 to 15 employees, by recruiting tech, product, and data talent. At the same time, Faks is expanding internationally, focusing on Spain and Italy, two strategic high-potential markets.
“This funding marks a key milestone for Faks. After bringing together major industry players on one platform that simplifies their interactions, we are now investing heavily in our technology to help them save even more time and focus on what matters most: their patients,” said Corentin Geoffray, CEO and co-founder of Faks.
Building the digital backbone for pharmacies
Corentin Geoffray, Clément Goupy (ex-L’Oréal & ex-Danone), and Félix Pignard (ex-Microsoft & ex-Amazon) founded Faks in 2020 to address persistent challenges in the pharmaceutical sector. As childhood friends, Geoffray and Goupy were surprised by the lack of digital solutions between pharmacies and laboratories. They discovered that pharmacy-supplier interactions were severely under-digitized, creating inefficiencies and burdensome processes.
While medical services and pharmacies have undergone accelerated digital transformation since the COVID-19 crisis, commercial interactions between pharmacies, pharmacy associations, and laboratories remain fragmented and outdated.
Faks addresses these challenges with a digital platform that streamlines pharmacy-supplier interactions and simplifies after-sales operations, including promotion management, claims processing, and expired product returns. This solution enables pharmacies to dedicate more time to patient care while enhancing operational efficiency for suppliers’ sales and support teams.
Geoffray told TFN: “Faks was created in response to a clear market need. The pharmaceutical sector is one of the least digitised industries, with pharmacists still relying on manual processes like emails, Excel sheets, and handwritten notes to manage supplier relations. A pharmacy collaborates with around 100 different laboratories, making commercial interactions complex and time-consuming. Pharmacists were actively looking for a solution to centralise their interactions, reduce administrative burdens, and free up time for patient care.”
The company maintains independence from pharmacy associations and pharmaceutical laboratories. It provides pharmacies with access to a neutral, user-friendly platform where they can manage all post-sales operations in one place, including promotions, claims, expired product management, and more.
Since its founding in 2020, Faks has become the leading B2B platform in the pharmaceutical sector, connecting over 17,000 pharmacies, 500 laboratories, and 130 pharmacy associations. Today, 85% of French pharmacies use Faks.
AI-powered efficiency is behind Faks’ platform
While Faks is making strides in the French market with its AI-powered pharmacy management platform, it faces competition from established players like PioneerRx and BestRx and emerging AI-focused companies such as Streebo. All these companies are vying to transform pharmacy operations and improve efficiency in the pharmaceutical sector.
Speaking about the technology and its capabilities, Geoffray explained: “Unlike traditional fragmented tools, Faks offers a single interface where pharmacists can handle all post-sales operations—promotions, claims, transactions, etc.—from multiple suppliers. Future developments include ‘Faks Copilot,’ an AI assistant to further optimise pharmacists’ daily workflows. Upcoming features will include AI-driven supplier interactions, improving how pharmacies manage their commercial relationships.”
Faks’ “Faks Copilot” development reflects a growing trend of AI integration in pharmacy operations. AI-powered virtual assistants are becoming increasingly common in the pharmaceutical sector, offering benefits such as automated transcription of customer calls for order placement, personalised medication recommendations based on patient data, inventory management optimisation and demand prediction, and detection of potential drug interactions and adverse events.
Wissam Nasreddine, Principal at Speedinvest, said: “The growing diversification of pharmacies’ activities, on top of their most important role of advising patients, has left little time to manage back-office operations from order to stock management. We see huge potential in centralising all their supplier interactions in a single platform and automating tedious yet strategic tasks with AI.”
